Showing results (11-20 of 96) with videos related to
Sort By:
Pageof 10
Drug Safety|November 1, 1991
Adverse drug reactions leading to hospital admissionL Ibáñez, J R Laporte, X CarnéJournal of Molecular and Cellular Cardiology|March 1, 1994
Phorbol ester-induced potentiation of myogenic tone is not associated with increases in Ca2+ influx, myoplasmic free Ca2+ concentration, or 20-kDa myosin light chain phosphorylationR Laporte, J R Haeberle, I LaherNeurology|October 27, 2004
Oral antispastic drugs in nonprogressive neurologic diseases: a systematic reviewE Montané, A Vallano, J R LaporteEuropean Journal of Clinical Pharmacology|January 1, 1983
Utilization of antihypertensive drugs in certain European countriesD Capellà, M Porta, J R LaporteViolence and Victims|July 27, 1999
Capture-recapture analysis of batterer reassaults: an epidemiological innovation for batterer program evaluationE W Gondolf, Y F Chang, R LaporteEuropean Journal of Clinical Pharmacology|January 1, 1994
Clinical trials versus clinical practice in the secondary prevention of myocardial infarctionA Agustí, J M Arnau, J R LaporteMedicina Clinica|March 4, 1989
[Use of benzodiazepines at a general hospital]A Figueras, J M Arnau, J R LaporteBritish Journal of Clinical Pharmacology|September 1, 1984
The potentiation of acenocoumarol anticoagulant effect by amiodaroneM Arboix, M E Frati, J R LaporteDiabetologia|October 1, 1993
A review of the recent epidemiological data on the worldwide incidence of type 1 (insulin-dependent) diabetes mellitus. World Health Organization DIAMOND Project GroupM Karvonen, J Tuomilehto, I Libman, et al.European Journal of Pharmacology|November 24, 1992
Further evidence from an elastic artery that angiotensin II amplifies noradrenaline-induced contraction through activation of protein kinase CD Henrion, I Laher, R Laporte, et al.Pageof 10